5Loeffler J,Stevens DA. Antifungal drug resistance. Clin Infect Dis,2003,36 (Suppl 1):S31-S41.
6Greer ND. Voficonazole: the newest triazole antifungal agent. Proc(Bayl Univ Med Cent) ,2003,16:241-248.
7Pappas PG, Rex JH, Sobel JD, et al. Guidelines for treatment of candidiasis. Clin Infect Dis,2004,38: 161-189.
8Boyd AE, Modi S, Howard S.I, et al. Adverse reactions to voriconazole. Clin Infect Dis,2004,39:1241-1244.
9Deresinski SC,Stevens DA. Caspofungin. Clin Infect Dis,2003,36:1445-1457.
10Pfaller MA, Boyken L, Hollis RJ, et al. In vitro activities of anidulafungin against more than 2,500 clinical isolates of Candida spp., including 315 isolates resistant to fluconazole. J Clin Microbio1,2005,43:5425-5427.